| CAS: | 915082-52-9 | |||||
| 分子式: | C19H18ClN3O2S | |||||
| 分子量: | 387.88 | |||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 | ||||||||||||||||||||||||
| P937910 | MACKLIN | A 33 | 98% | 1018元/5mg; 1724元/10mg; 3336元/25mg; | 展开 | ||||||||||||||||||||||||
储存:2-8°C,密封,干燥 状态:白色到米黄色粉末 | |||||||||||||||||||||||||||||
| SML2121 | Sigma-Aldrich | A-33 | ≥98% (HPLC) | 1465.19元/5 MG; 5911.08元/25 MG; | 展开 | ||||||||||||||||||||||||
产品说明 生化/生理作用 A-33 (A33) is a potent and selective catalytic site-targeting PDE4B inhibitor (IC50 = 15 nM/PDE4B vs. 1.7 μM/PDE4D) that effectively prevents PDE4B-medicated cellular cAMP hydrolysis (150%/320% increased cAMP level with 100 nM/1 μM A-33 pre-treament in murine hippocampal HT-22 cells following 10 nM isoproterenol stimulation) in vitro and inhibits LPS-induced TNF-α production in mice in vivo (ID50 = 14 mg/kg p.o.). When administered via intraperitoneal injection, A-33 improves cognitive function in a rat model of traumatic brain injury (0.3 mg/kg i.p.) and exhibits antidepressant property in mice (0.3-1 mg/kg i.p.) in vivo. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||